{"identifier":"/us/usc/t42/s285s","title_num":"42","num":"§ 285s.","heading":"Purpose of Institute","status":null,"guid":"id5f87a17e-4aa7-11eb-94f5-9ff2c44f6f3c","source_credit":"(July 1, 1944, ch. 373, title IV, § 464z–1, formerly § 485B, as added Pub. L. 103–43, title XV, § 1521(2), June 10, 1993, 107 Stat. 180; renumbered § 464z–1 and amended Pub. L. 109–482, title I, § 101(c)(4), Jan. 15, 2007, 120 Stat. 3681.)","seq_in_title":596,"parent_identifier":"/us/usc/t42/ch6A/schIII/ptC/spt19","ancestors":[{"identifier":"/us/usc/t42","level":"title","num":"Title 42—","heading":"THE PUBLIC HEALTH AND WELFARE","status":null,"is_section":false},{"identifier":"/us/usc/t42/ch6A","level":"chapter","num":"CHAPTER 6A—","heading":"PUBLIC HEALTH SERVICE","status":null,"is_section":false},{"identifier":"/us/usc/t42/ch6A/schIII","level":"subchapter","num":"SUBCHAPTER III—","heading":"NATIONAL RESEARCH INSTITUTES","status":null,"is_section":false},{"identifier":"/us/usc/t42/ch6A/schIII/ptC","level":"part","num":"Part C—","heading":"Specific Provisions Respecting National Research Institutes","status":null,"is_section":false},{"identifier":"/us/usc/t42/ch6A/schIII/ptC/spt19","level":"subpart","num":"subpart 19—","heading":"national human genome research institute","status":null,"is_section":false}],"xml":"<section xmlns=\"http://xml.house.gov/schemas/uslm/1.0\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\" xmlns:dcterms=\"http://purl.org/dc/terms/\" style=\"-uslm-lc:I80\" id=\"ida4bd9ffe-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s\"><num value=\"285s\">§ 285s.</num><heading> Purpose of Institute</heading><subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"ida4bd9fff-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/a\"><num value=\"a\" class=\"bold\">(a)</num><heading class=\"bold\"> General purpose</heading><chapeau style=\"-uslm-lc:I11\" class=\"indent0\">The general purpose of the National Human Genome Research Institute (in this subpart referred to as the “Institute”) is to characterize the structure and function of the human genome, including the mapping and sequencing of individual genes. Such purpose includes—</chapeau><paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4bda000-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/a/1\"><num value=\"1\">(1)</num><content> planning and coordinating the research goal of the genome project;</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4bda001-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/a/2\"><num value=\"2\">(2)</num><content> reviewing and funding research proposals;</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4bda002-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/a/3\"><num value=\"3\">(3)</num><content> developing training programs;</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4bda003-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/a/4\"><num value=\"4\">(4)</num><content> coordinating international genome research;</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4bda004-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/a/5\"><num value=\"5\">(5)</num><content> communicating advances in genome science to the public; and</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4bda005-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/a/6\"><num value=\"6\">(6)</num><content> reviewing and funding proposals to address the ethical and legal issues associated with the genome project (including legal issues regarding patents).</content>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"ida4bda006-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/b\"><num value=\"b\" class=\"bold\">(b)</num><heading class=\"bold\"> Research training</heading><chapeau style=\"-uslm-lc:I11\" class=\"indent0\">The Director of the Institute may conduct and support research training—</chapeau><paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4bda007-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/b/1\"><num value=\"1\">(1)</num><content> for which fellowship support is not provided under <ref href=\"/us/usc/t42/s288\">section 288 of this title</ref>; and</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I12\" class=\"indent1\" id=\"ida4bda008-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/b/2\"><num value=\"2\">(2)</num><content> that is not residency training of physicians or other health professionals.</content>\n</paragraph>\n</subsection>\n<subsection style=\"-uslm-lc:I19\" class=\"indent2 firstIndent-2\" id=\"ida4bda009-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/c\"><num value=\"c\" class=\"bold\">(c)</num><heading class=\"bold\"> Amount available for ethical and legal issues</heading><paragraph style=\"-uslm-lc:I11\" class=\"indent0\" id=\"ida4bda00a-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/c/1\"><num value=\"1\">(1)</num><content> Except as provided in paragraph (2), of the amounts appropriated to carry out subsection (a) for a fiscal year, the Director of the Institute shall make available not less than 5 percent for carrying out paragraph (6) of such subsection.</content>\n</paragraph>\n<paragraph style=\"-uslm-lc:I11\" class=\"indent0\" id=\"ida4bda00b-09a0-11eb-a85b-f5cef3d06f4d\" identifier=\"/us/usc/t42/s285s/c/2\"><num value=\"2\">(2)</num><content> With respect to providing funds under subsection (a)(6) for proposals to address the ethical issues associated with the genome project, paragraph (1) shall not apply for a fiscal year if the Director of the Institute certifies to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, that the Director has determined that an insufficient number of such proposals meet the applicable requirements of sections 289 and 289a of this title.</content>\n</paragraph>\n</subsection>\n<sourceCredit id=\"ida4bdc71c-09a0-11eb-a85b-f5cef3d06f4d\">(<ref href=\"/us/act/1944-07-01/ch373\">July 1, 1944, ch. 373</ref>, title IV, § 464z–1, formerly § 485B, as added <ref href=\"/us/pl/103/43/tXV/s1521/2\">Pub. L. 103–43, title XV, § 1521(2)</ref>, <date date=\"1993-06-10\">June 10, 1993</date>, <ref href=\"/us/stat/107/180\">107 Stat. 180</ref>; renumbered § 464z–1 and amended <ref href=\"/us/pl/109/482/tI/s101/c/4\">Pub. L. 109–482, title I, § 101(c)(4)</ref>, <date date=\"2007-01-15\">Jan. 15, 2007</date>, <ref href=\"/us/stat/120/3681\">120 Stat. 3681</ref>.)</sourceCredit>\n<notes type=\"uscNote\" id=\"ida4bdc71d-09a0-11eb-a85b-f5cef3d06f4d\">\n<note style=\"-uslm-lc:I76\" topic=\"codification\" id=\"ida4bdc71e-09a0-11eb-a85b-f5cef3d06f4d\"><heading class=\"centered smallCaps\">Codification</heading>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">Section was formerly classified to <ref href=\"/us/usc/t42/s287c\">section 287c of this title</ref> prior to renumbering by <ref href=\"/us/pl/109/482\">Pub. L. 109–482</ref>.</p>\n</note>\n<note style=\"-uslm-lc:I74\" topic=\"amendments\" id=\"ida4bdc71f-09a0-11eb-a85b-f5cef3d06f4d\"><heading class=\"centered smallCaps\">Amendments</heading><p style=\"-uslm-lc:I21\" class=\"indent0\">2007—<ref href=\"/us/pl/109/482/s101/c/4/C\">Pub. L. 109–482, § 101(c)(4)(C)</ref>, substituted “Institute” for “Center” wherever appearing in section catchline and text.</p>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">Subsec. (a). <ref href=\"/us/pl/109/482/s101/c/4/B\">Pub. L. 109–482, § 101(c)(4)(B)</ref>, substituted “National Human Genome Research Institute” for “National Center for Human Genome Research” in introductory provisions.</p>\n</note>\n<note style=\"-uslm-lc:I78\" topic=\"changeOfName\" id=\"ida4bdc720-09a0-11eb-a85b-f5cef3d06f4d\">\n<heading class=\"centered smallCaps\">Change of Name</heading>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">Committee on Labor and Human Resources of Senate changed to Committee on Health, Education, Labor, and Pensions of Senate by Senate Resolution No. 20, One Hundred Sixth Congress, <date date=\"1999-01-19\">Jan. 19, 1999</date>.</p>\n<p style=\"-uslm-lc:I21\" class=\"indent0\">Committee on Energy and Commerce of House of Representatives treated as referring to Committee on Commerce of House of Representatives by <ref href=\"/us/pl/104/14/s1/a\">section 1(a) of Pub. L. 104–14</ref>, set out as a note preceding <ref href=\"/us/usc/t2/s21\">section 21 of Title 2</ref>, The Congress. Committee on Commerce of House of Representatives changed to Committee on Energy and Commerce of House of Representatives, and jurisdiction over matters relating to securities and exchanges and insurance generally transferred to Committee on Financial Services of House of Representatives by House Resolution No. 5, One Hundred Seventh Congress, <date date=\"2001-01-03\">Jan. 3, 2001</date>.</p>\n</note>\n<note style=\"-uslm-lc:I74\" topic=\"effectiveDateOfAmendment\" id=\"ida4bdc721-09a0-11eb-a85b-f5cef3d06f4d\"><heading class=\"centered smallCaps\">Effective Date of 2007 Amendment</heading><p style=\"-uslm-lc:I21\" class=\"indent0\">Amendment by <ref href=\"/us/pl/109/482\">Pub. L. 109–482</ref> applicable only with respect to amounts appropriated for fiscal year 2007 or subsequent fiscal years, see <ref href=\"/us/pl/109/482/s109\">section 109 of Pub. L. 109–482</ref>, set out as a note under <ref href=\"/us/usc/t42/s281\">section 281 of this title</ref>.</p>\n</note>\n</notes>\n</section>","provision":null,"duplicates":[],"release":{"label":"116-252","currency_date":"2020-12-22","congress":116,"law_num":252,"excluded_laws":[],"update_num":null,"seq":222,"is_partial":false,"caveat":null,"titles_affected":["18","20","31","34","40","42"],"ingested_titles":[]},"served_from":{"label":"116-252","currency_date":"2020-12-22","congress":116,"law_num":252,"excluded_laws":[],"update_num":null,"seq":222,"is_partial":false,"caveat":null,"titles_affected":["18","20","31","34","40","42"],"ingested_titles":[]},"content_first_seen":{"label":"116-163","currency_date":"2020-10-02","congress":116,"law_num":163,"excluded_laws":[],"update_num":null,"seq":214,"is_partial":false,"caveat":null,"titles_affected":["01","02","03","06","07","08","10","15","17","18","21","22","23","26","28","31","35","36","38","40","42","45","49","50"],"ingested_titles":[]},"is_exact":true,"note":null}